Theranica Reports | AI Achieves 91% Precision on Next-Day Migraine Likelihood in Largest Study of Its Kind

Peer-reviewed study of 53,000 Nerivio users finds a patient’s own headache pattern over the past 30 days, not the prodromal symptoms clinicians have watched for decades, is the strongest warning sign of tomorrow’s migraine attack

← Previous
Next →
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTEREST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTEREST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.